Preliminary Efficacy of an Emotion Regulation Intervention on Physical Activity and Depressive and Anxious Symptoms in Individuals in Cardiac Rehabilitation.
Preliminary Efficacy of an Emotion Regulation Intervention on Physical Activity and Depressive and Anxious Symptoms in Individuals in Cardiac Rehabilitation.
复制标题
DOI：
10.1097/jcn.0000000000000837
复制
发表时间：
2022-05-01
期刊：
影响因子：
--
通讯作者：
Moore SM
中科院分区：
文献类型：
--
作者：
Wierenga KL;Fresco DM;Alder M;Sattar A;Moore SM
对于预计今年将经历新的急性心脏事件的 72 万美国人来说，心脏康复是康复的重要组成部分。抑郁和焦虑的症状会破坏康复工作，使康复中的患者面临功能能力下降和死亡风险增加的风险。情绪调节不良会加重抑郁和焦虑症状，并阻碍康复工作。这项随机对照试验的目的是评估基于理论的情绪调节治疗 (RENEwS) 的早期疗效测试，该治疗旨在帮助急性心脏事件幸存者进行心脏康复，以优化康复。心脏康复中的急性心脏事件幸存者（n = 30，83% 为男性）被随机分配到 5 个一小时的面对面 RENEwS 小组或基于电话的注意力控制组。参与者在三个时间点完成了抑郁和焦虑症状的测量。使用腰戴式体动监测仪在 7 天的每个时间点客观测量中度至剧烈体力活动 (MVPA)。使用方差分析计算组间差异，并计算科恩 f 效应大小以评估初始疗效。根据分组情况，随着时间的推移，抑郁、焦虑或 MVPA 没有统计学上的显着差异（所有 p > .05）。与注意力控制参与者（RENEwS 参与者）相比，初步效果显示抑郁症（Cohen's f = .34）和焦虑症状（Cohen's f = .40）有更大程度的减少，但从基线到 5 个月的 MVPA 仅略有改善（Cohen's f = .08）。研究结果表明，RENEwS 是一种很有前途的情绪调节干预措施，可增强心脏康复并可能减少抑郁和焦虑症状。
For the 720,000 Americans expected to experience an new acute cardiac event this year, cardiac rehabilitation is an important part of recovery. Symptoms of depression and anxiety undermine recovery efforts leaving recovering patients at risk for diminished functional capacity and heightened risk of mortality. Poor emotion regulation can worsen symptoms of depression and anxiety and hinder recovery efforts. The purpose of this randomized control trial was to evaluate the early efficacy testing of a theoretically based emotion regulation treatment (RENEwS) designed to assist acute cardiac event survivors in cardiac rehabilitation to optimize recovery. Acute cardiac event survivors in cardiac rehabilitation (n=30, 83% men) were randomized to 5 one-hour, in-person group sessions of RENEwS or a phone-based attention-control group. Participants completed measures of depression and anxiety symptoms at three timepoints. Moderate to vigorous physical activity (MVPA) was objectively measured for 7 days at each time point using waist-worn actigraphy monitors. Between-group differences were calculated using ANOVA with Cohen’s f effect sizes calculated to evaluate initial efficacy. There was no statistically significant difference in depression, anxiety or MVPA over time based on group assignment (all p > .05). Compared to attention-control participants, RENEwS participants, preliminary effects showed greater reductions in depression (Cohen’s f = .34) and anxiety symptoms (Cohen’s f = .40) but only modest improvements in MVPA from baseline to 5 months (Cohen’s f = .08). Findings show that RENEwS is a promising emotion regulation intervention to enhance cardiac rehabilitation and potentially decrease symptoms of depression and anxiety.
影响因子：
1.8
作者：
Wierenga, Kelly L.;Fresco, David M.;Alder, Megan;Moore, Shirley M.
通讯作者：
Moore, Shirley M.